MIL-therapy / Method of treatment / 2. Mechanism of biological and therapeutic action produced by constant magnetic field (CMF). Magnet-laser therapy ( MIL)
2. Mechanism of biological and therapeutic action produced by constant magnetic field (CMF). Magnet-laser therapy ( MIL)
In the natural environment living beings are incurring the impact of the Earth magnetic field, local magnetic anomalies caused by mineral deposits, etc. Artificial magnets and generators of magnetic fields have been successfully applied for therapeutic purposes in modern medicine for a long time. Constant magnetic field (CMF) of any intensity from 10 up to 100 mTl may be considered as a non-specific irritator of biological tissues. It is defined that CMF of therapeutical tension (10-60 mTl) changes the orientation links - electrostatic interaction between dipoles (for instance, in the membrane phospholipid component), ion links and ion-dipole interactions (for instance, in chelate bonds). It also affects induction and dispersion links (for instance, in complex lipoproteid submolecular complexes retained in specific structures by electrostatic forces).
CNS, blood and endocrine system are living structures most sensitive to CMF. In CNS we can see a protective inhibition with a slight elevation of irritation threshold, i.e. exitation is decreased. In the endocrine system we can see a moderate functional activity of thyroid and genital glands, trophic hypophysis hormones (except ACTG), the increase of glycocorticoids secretion in the adrenal cortex. Retardation of catabolic and synthesis processes, as well as anti-inflammatory effects are also observed. Biological effects may be seen right after the first CMF application.
CMF vasodilatative and disagregative effects (5-10 mTl) are mostly developed at the microcirculation level while the systemic circulation is left almost intact. It is explained by the fact that biological effects of low intensive CMF coordinate three main balance parameters: microcirculation, vasodilatation, disagregation. CMF interacts with moving electrically charged particles, in particular, with the erythrocytes. It determines CMF selective effect at blood coagulation, microcirculation and microvessels permeability.
Therapeutic effects of LED and laser radiation (especially infrared) at biological tissues are significantly increased in the magnetic field. It takes place because of the multilevel and diversely directed activation of microcirculation, because of the increase in the activity of tissue metabolism, because of the intensification of humoral element functions as well as other factors determining more active functions in a biological object. LILR destroys electric bonds between ions, water molecules and ions, whereas CMF prevents ion recombination. The pointed electric moving force (EMF) is much more higher under the combined LILR and CMF effect than under their separate effect; the depth of penetration of laser radiation into tissues is increased because of the dipoles reorientation. Clinical application of LILR combined with CMF has been called magnetic laser therapy, MLT.
Experiments have shown that MLT in therapeutic doses restores the intracellular Ca2+ balance in pathologically changed tissues and organs because of the activation of endogenous mechanisms decreasing Ca2+ permeability of cellular plasma membrane. It is known that the modification of intracellular Ca2+ balance is seen in cardiovascular pathology, renal insufficiency and other diseases. Metabolic and structural changes in cells and subcellular formations taking place under MLT determine a strong regenerative effect of MIL-therapy.
Non-specific, trigger character of MIL-therapy is transmitted through the central nervous system and finally is revealed in the systemic reactions. Location of MIL-therapy is not important because any part of the body is connected to this or that organ through CNS. Curative effect of MIL-therapy is determined by the biostimulation and mobilization of the existing energetic potential and is manifested as immune-modulating, desensibilising, neutrophic, anti-inflammatory, anesthetic, antiedematous, regenerative, normalizing blood rheology and hemodinamics, hypocholesterolemic. It has determined a wide range of indications for MIL-therapy and variety of therapeutic approaches.
MIL-therapy is effective in different diseases because it impacts their common pathogenic chains by the combination of its mechanisms. LILR spectrum of non-specific regulative effects may be compared with the adaptogens of different nature, vitamins, polinonsaturated fat acids, irreplacable aminoacids (which are not synthesized in the organism), natural antioxidants, metabolically active substances, immune modulators and immune stimulators. To achieve better effect in MIL-therapy it is important to have an integral approach to the analysis of the disease and to the ways of its treatment.